Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. https://doi.org/10.1038/nature07205.
Article CAS PubMed Google Scholar
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013.
Article CAS PubMed Google Scholar
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–99. https://doi.org/10.1016/j.cell.2010.01.025.
Article CAS PubMed PubMed Central Google Scholar
Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220–8. https://doi.org/10.1038/nrm2858.
Article CAS PubMed Google Scholar
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30(7):1073–81. https://doi.org/10.1093/carcin/bgp127.
Article CAS PubMed Google Scholar
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. https://doi.org/10.1016/j.cell.2010.03.014.
Article CAS PubMed PubMed Central Google Scholar
Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Chapter 3 - Regulatory T cells in cancer. In: Vande Woude GF, Klein G, editors. Advances in Cancer Research. Academic Press; 2010. p. 57–117.
Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21(6):345–59. https://doi.org/10.1038/s41568-021-00347-z.
Article CAS PubMed PubMed Central Google Scholar
Guner A, Kim HI. Biomarkers for evaluating the inflammation status in patients with cancer. J Gastric Cancer. 2019;19(3):254–77. https://doi.org/10.5230/jgc.2019.19.e29.
Article PubMed PubMed Central Google Scholar
Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, et al. Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol. 2018;4(3):351–7. https://doi.org/10.1001/jamaoncol.2017.4771.
Article PubMed PubMed Central Google Scholar
Kazandjian D, Gong Y, Keegan P, Pazdur R, Blumenthal GM. Prognostic value of the lung immune prognostic index for patients treated for metastatic non-small cell lung cancer. JAMA Oncol. 2019;5(10):1481–5. https://doi.org/10.1001/jamaoncol.2019.1747. This study validated the lung immune prognostic index in patients with pretreated aNSCLC by a pooled analysis of randomised controlled trials with immunotherapy.
Article PubMed PubMed Central Google Scholar
Wang Y, Li Y, Chen P, Xu W, Wu Y, Che G. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med. 2019;7(18):433. https://doi.org/10.21037/atm.2019.08.116.
Article CAS PubMed PubMed Central Google Scholar
Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, et al. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion. Sci Rep. 2019;9(1):4721. https://doi.org/10.1038/s41598-019-41289-9.
Article CAS PubMed PubMed Central Google Scholar
Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771–6. https://doi.org/10.1016/j.cell.2010.03.006.
Article CAS PubMed Google Scholar
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. https://doi.org/10.1016/j.cell.2006.02.015.
Article CAS PubMed Google Scholar
Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T, et al. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 2003;94(3):244–52. https://doi.org/10.1111/j.1349-7006.2003.tb01428.x.
Article CAS PubMed Google Scholar
Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. https://doi.org/10.1016/j.immuni.2019.06.025.
Article CAS PubMed PubMed Central Google Scholar
Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74–80. https://doi.org/10.1126/science.aaa6204.
Article CAS PubMed Google Scholar
Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166. https://doi.org/10.1038/s41392-020-00280-x.
Article PubMed PubMed Central Google Scholar
Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol. 2006;176(1):284–90. https://doi.org/10.4049/jimmunol.176.1.284.
Article CAS PubMed Google Scholar
Chen L, Huang CF, Li YC, Deng WW, Mao L, Wu L, et al. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma. Cell Mol Life Sci. 2018;75(11):2045–58. https://doi.org/10.1007/s00018-017-2720-9.
Article CAS PubMed Google Scholar
Chaudhry SI, Hooper S, Nye E, Williamson P, Harrington K, Sahai E. Autocrine IL-1beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFalpha signalling to carcinoma-associated fibroblasts. Oncogene. 2013;32(6):747–58. https://doi.org/10.1038/onc.2012.91.
Article CAS PubMed Google Scholar
Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–24. https://doi.org/10.1038/nri.2017.142.
Article CAS PubMed Google Scholar
Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res. 2006;12(4):1088–96. https://doi.org/10.1158/1078-0432.CCR-05-1603.
Article CAS PubMed Google Scholar
Kim JW, Koh Y, Kim DW, Ahn YO, Kim TM, Han SW, et al. Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with advanced non-small cell lung cancer. Cancer Res Treat. 2013;45(4):325–33. https://doi.org/10.4143/crt.2013.45.4.325.
Article PubMed PubMed Central Google Scholar
Millares L, Barreiro E, Cortes R, Martinez-Romero A, Balcells C, Cascante M, et al. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: local patterns and prognostic significance. Lung Cancer. 2018;122:124–30. https://doi.org/10.1016/j.lungcan.2018.06.015.
de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol. 2006;13:118–37. https://doi.org/10.1159/000092969.
Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 2008;66(1):1–9. https://doi.org/10.1016/j.critrevonc.2007.07.004.
Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591–6. https://doi.org/10.1242/jcs.116392.
Article CAS PubMed Google Scholar
Jang JH, Kim DH, Surh YJ. Dynamic roles of inflammasomes in inflammatory tumor microenvironment. NPJ Precis Oncol. 2021;5(1):18. https://doi.org/10.1038/s41698-021-00154-7.
Article CAS PubMed PubMed Central Google Scholar
Leach M. Interpretation of the full blood count in systemic disease—a guide for the physician. J R Coll Phys Edinb. 2014;44(1):36–41. https://doi.org/10.4997/JRCPE.2014.109.
Velioglu Y, Yuksel A. Complete blood count parameters in peripheral arterial disease. Aging Male. 2019;22(3):187–91. https://doi.org/10.1080/13685538.2019.1588873.
Article CAS PubMed Google Scholar
Zinellu A, Paliogiannis P, Sotgiu E, Mellino S, Mangoni AA, Zinellu E, et al. Blood Cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis. Lung. 2020;198(5):821–7. https://doi.org/10.1007/s00408-020-00386-7.
Article CAS PubMed PubMed Central Google Scholar
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30. https://doi.org/10.1016/j.critrevonc.2013.03.010.
Sacdalan DB, Lucero JA, Sacdalan DL. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. Onco Targets Ther. 2018;11:955–65. https://doi.org/10.2147/OTT.S153290.
留言 (0)